Taipei Medical University and Sharesmile Biotechnology Advance OSA Technology Transfer

In recent years, sleep disorders have become increasingly prevalent in Taiwan, with obstructive sleep apnea (OSA) recognized as a key condition affecting sleep quality and overall health. While current management options such as surgery and CPAP therapy are available, limitations in invasiveness and usability mean that many patients remain untreated, highlighting the need for safer and more user-friendly adjunctive solutions.

Since 2020, Taipei Medical University has brought together expertise from dentistry and pulmonology to conduct interdisciplinary research, incorporating artificial intelligence (AI)–based image analysis to develop a patient-specific oral device. Designed as a non-invasive option worn during sleep, the device is being explored as an adjunctive approach in clinical evaluation, with outcomes subject to individual assessment by qualified healthcare professionals.
 

To facilitate practical application of the research outcomes, Taipei Medical University has recently completed a technology transfer agreement with Sharesmile Biotechnology Co., Ltd., licensing a manufacturing method for an oral appliance related to obstructive sleep apnea. Through this industry–academia collaboration, Sharesmile Biotechnology will continue to advance AI-enabled sleep medical technologies and expand domestic and international research partnerships to support further development in this field.



Sharesmile Biotechnology is an emerging biotechnology company in Taiwan, with a long-term focus on research and applications in AI-enabled sleep medical technologies. This technology transfer collaboration represents an important milestone in translating academic research into practical applications. Looking ahead, Shell Biotechnology will continue to engage in domestic and international industry–academia partnerships to advance innovation in sleep medicine and expand global collaboration opportunities for Taiwan’s medical technology sector.